Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates strategies to identify prophylactic and therapeutic drug candidates to enter rapid clinical development. This is particularly true, given the uncerta...

Descripción completa

Detalles Bibliográficos
Autores principales: Allegretti, Marcello, Cesta, Maria Candida, Zippoli, Mara, Beccari, Andrea, Talarico, Carmine, Mantelli, Flavio, Bucci, Enrico M., Scorzolini, Laura, Nicastri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370058/
https://www.ncbi.nlm.nih.gov/pubmed/34404919
http://dx.doi.org/10.1038/s41418-021-00844-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370058/
https://www.ncbi.nlm.nih.gov/pubmed/34404919
http://dx.doi.org/10.1038/s41418-021-00844-6

Ejemplares similares